Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.
2.

Discriminatory ability of fractal and grey level co-occurrence matrix methods in structural analysis of hippocampus layers.

Pantic I, Dacic S, Brkic P, Lavrnja I, Jovanovic T, Pantic S, Pekovic S.

J Theor Biol. 2015 Apr 7;370:151-6. doi: 10.1016/j.jtbi.2015.01.035. Epub 2015 Feb 7.

PMID:
25665716
3.

Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.

Schneider F, Smith MA, Lane MC, Pantanowitz L, Dacic S, Ohori NP.

Am J Clin Pathol. 2015 Feb;143(2):193-200; quiz 306. doi: 10.1309/AJCPMY8UI7WSFSYY.

PMID:
25596245
4.

Effect of stab injury in the rat cerebral cortex on temporal pattern of expression of neuronal cytoskeletal proteins: An immunohistochemical study.

Lavrnja I, Savic D, Parabucki A, Dacic S, Laketa D, Pekovic S, Stojiljkovic M.

Acta Histochem. 2015 Mar;117(2):155-62. doi: 10.1016/j.acthis.2014.12.004. Epub 2015 Jan 13.

PMID:
25592752
5.

[Scanning electron microscopy analysis of marginal adaptation of composite resines to enamel after using of standard and gradual photopolimerization].

Dacić S, Dacić-Simonović D, Zivković S, Dacić M, Radicević G, Mitić A, Tosić G, Igić M.

Srp Arh Celok Lek. 2014 Jul-Aug;142(7-8):404-12. Serbian.

PMID:
25233683
6.

Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study.

Thunnissen E, Noguchi M, Aisner S, Beasley MB, Brambilla E, Chirieac LR, Chung JH, Dacic S, Geisinger KR, Hirsch FR, Ishikawa Y, Kerr KM, Lantejoul S, Matsuno Y, Minami Y, Moreira AL, Pelosi G, Petersen I, Roggli V, Travis WD, Wistuba I, Yatabe Y, Dziadziuszko R, Witte B, Tsao MS, Nicholson AG.

J Thorac Oncol. 2014 Sep;9(9):1354-62. doi: 10.1097/JTO.0000000000000264.

PMID:
25122431
7.

Comprehensive molecular profiling of lung adenocarcinoma.

Cancer Genome Atlas Research Network.

Nature. 2014 Jul 31;511(7511):543-50. doi: 10.1038/nature13385. Epub 2014 Jul 9. Erratum in: Nature. 2014 Oct 9;514(7521):262. Rogers, K [corrected to Rodgers, K].

8.

Application of fractal and grey level co-occurrence matrix analysis in evaluation of brain corpus callosum and cingulum architecture.

Pantic I, Dacic S, Brkic P, Lavrnja I, Pantic S, Jovanovic T, Pekovic S.

Microsc Microanal. 2014 Oct;20(5):1373-81. doi: 10.1017/S1431927614012811. Epub 2014 Jun 26.

PMID:
24967845
9.

Reply to verification bias in diagnostic accuracy studies for fine-needle aspiration cytology.

Karunamurthy A, Cai G, Dacic S, Khalbuss WE, Pantanowitz L, Monaco SE.

Cancer Cytopathol. 2014 Jun;122(6):474-5. doi: 10.1002/cncy.21432. Epub 2014 Apr 18. No abstract available.

PMID:
24753510
10.

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer.

Kelly LM, Barila G, Liu P, Evdokimova VN, Trivedi S, Panebianco F, Gandhi M, Carty SE, Hodak SP, Luo J, Dacic S, Yu YP, Nikiforova MN, Ferris RL, Altschuler DL, Nikiforov YE.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4233-8. doi: 10.1073/pnas.1321937111. Epub 2014 Feb 3.

11.

Correlation of cytomorphology and molecular findings in EGFR+, KRAS+, and ALK+ lung carcinomas.

Li Z, Dacic S, Pantanowitz L, Khalbuss WE, Nikiforova MN, Monaco SE.

Am J Clin Pathol. 2014 Mar;141(3):420-8. doi: 10.1309/AJCPHF51LSPCAXTA.

12.

Present and future molecular testing of lung carcinoma.

Dacic S, Nikiforova MN.

Adv Anat Pathol. 2014 Mar;21(2):94-9. doi: 10.1097/PAP.0000000000000012. Review.

PMID:
24508692
13.

Stromal reaction and prognosis in acinic cell carcinoma of the salivary gland.

Velicković LJ, Dimov I, Petrović D, Stojnev S, Dacić S, Velicković S, Stefanović V.

Vojnosanit Pregl. 2013 Dec;70(12):1155-8.

PMID:
24450262
14.

Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors.

Bastaki JM, Purgina BM, Dacic S, Seethala RR.

Head Neck Pathol. 2014;8(3):250-60. doi: 10.1007/s12105-014-0518-8. Epub 2014 Jan 21.

15.

RET rearrangements in lung adenocarcinoma and radiation.

Dacic S, Luvison A, Evdokimova V, Kelly L, Siegfried JM, Villaruz LC, Socinski MA, Nikiforov YE.

J Thorac Oncol. 2014 Jan;9(1):118-20. doi: 10.1097/JTO.0000000000000015.

PMID:
24346100
16.

Evaluation of endobronchial ultrasound-guided fine-needle aspirations (EBUS-FNA): correlation with adequacy and histologic follow-up.

Karunamurthy A, Cai G, Dacic S, Khalbuss WE, Pantanowitz L, Monaco SE.

Cancer Cytopathol. 2014 Jan;122(1):23-32. doi: 10.1002/cncy.21350. Epub 2013 Oct 11.

PMID:
24127207
18.

HepPar-1 expression in primary lung adenocarcinoma.

Yousem SA, Lale S, Dacic S.

Am J Clin Pathol. 2013 Aug;140(2):225-30. doi: 10.1309/AJCP4MXTNQRVOE2T.

19.

KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.

Krasinskas AM, Chiosea SI, Pal T, Dacic S.

Mod Pathol. 2014 Feb;27(2):262-70. doi: 10.1038/modpathol.2013.146. Epub 2013 Jul 26.

20.

A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer.

Ramalingam SS, Kotsakis A, Tarhini AA, Heron DE, Smith R, Friedland D, Petro DP, Raez LE, Brahmer JR, Greenberger JS, Dacic S, Hershberger P, Landreneau RJ, Luketich JD, Belani CP, Argiris A.

Lung Cancer. 2013 Sep;81(3):416-21. doi: 10.1016/j.lungcan.2013.06.002. Epub 2013 Jul 10.

PMID:
23849982
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk